| Primary |
| Hormone Replacement Therapy |
34.9% |
| Menopause |
28.3% |
| Menopausal Symptoms |
18.5% |
| Depression |
3.3% |
| Hypertension |
3.0% |
| Osteoporosis Prophylaxis |
1.4% |
| Hypothyroidism |
1.2% |
| Migraine |
1.2% |
| Diabetes Mellitus |
1.1% |
| Hot Flush |
1.1% |
| Hypercholesterolaemia |
0.8% |
| Osteoporosis |
0.8% |
| Breast Cancer |
0.7% |
| Anxiety |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Cardiovascular Event Prophylaxis |
0.6% |
| Hypersensitivity |
0.6% |
| Hormone Therapy |
0.5% |
| Labile Hypertension |
0.5% |
| Oedema |
0.5% |
|
| Uterine Leiomyoma |
10.3% |
| Weight Increased |
9.5% |
| Vomiting |
8.6% |
| Weight Decreased |
7.8% |
| Vulvovaginal Dryness |
7.3% |
| Breast Cancer |
6.9% |
| Progesterone Receptor Assay Positive |
4.3% |
| Surgery |
4.3% |
| Vaginal Haemorrhage |
4.3% |
| Tachycardia |
3.9% |
| Uterine Polyp |
3.9% |
| Scar |
3.4% |
| Ventricular Extrasystoles |
3.4% |
| Vertigo |
3.4% |
| Visual Impairment |
3.4% |
| Injury |
3.0% |
| Tricuspid Valve Incompetence |
3.0% |
| Ultrasound Abdomen Abnormal |
3.0% |
| Varicose Vein |
3.0% |
| Wheelchair User |
3.0% |
|
| Secondary |
| Hormone Replacement Therapy |
63.0% |
| Menopause |
8.3% |
| Menopausal Symptoms |
7.0% |
| Hot Flush |
3.1% |
| Vulvovaginal Dryness |
2.4% |
| Night Sweats |
1.9% |
| Mood Swings |
1.9% |
| Vulvovaginal Pain |
1.9% |
| Hormone Therapy |
1.7% |
| Hypertension |
1.4% |
| Drug Use For Unknown Indication |
1.2% |
| Depression |
1.2% |
| Oestrogen Replacement Therapy |
0.8% |
| Osteoarthritis |
0.8% |
| Hypothyroidism |
0.8% |
| Cardiovascular Event Prophylaxis |
0.7% |
| Rheumatoid Arthritis |
0.6% |
| Osteopenia |
0.4% |
| Bone Disorder |
0.4% |
| Arthritis |
0.4% |
|
| Breast Cancer |
37.7% |
| Breast Cancer Female |
30.8% |
| Breast Cancer Metastatic |
8.1% |
| Progesterone Receptor Assay Positive |
3.0% |
| Muscle Spasms |
2.4% |
| Vision Blurred |
2.0% |
| Breast Cancer Recurrent |
1.9% |
| Scar |
1.8% |
| Breast Cancer In Situ |
1.4% |
| Ovarian Cancer Metastatic |
1.4% |
| Uterine Leiomyoma |
1.3% |
| Condition Aggravated |
1.2% |
| Vaginal Haemorrhage |
1.1% |
| Ovarian Cancer |
1.0% |
| Postoperative Wound Complication |
1.0% |
| Weight Increased |
1.0% |
| Deep Vein Thrombosis |
0.8% |
| Weight Decreased |
0.8% |
| Breast Mass |
0.7% |
| Cerebrovascular Accident |
0.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.7% |
| Drug Use For Unknown Indication |
11.2% |
| Prophylaxis |
9.9% |
| Hypertension |
8.4% |
| Menopause |
5.4% |
| Hormone Replacement Therapy |
4.6% |
| Asthma |
4.3% |
| Breast Cancer |
4.0% |
| Gastrooesophageal Reflux Disease |
3.9% |
| Depression |
3.5% |
| Pain |
3.4% |
| Hiatus Hernia |
3.3% |
| Osteoporosis |
3.0% |
| Spondylitis |
3.0% |
| Primary Hypothyroidism |
2.8% |
| Hypogonadism Female |
2.7% |
| Chest Pain |
2.6% |
| Hypertensive Heart Disease |
2.6% |
| Hypothyroidism |
2.6% |
| Diabetes Mellitus |
2.4% |
|
| Vomiting |
12.2% |
| Macular Degeneration |
8.7% |
| Osteoarthritis |
8.7% |
| Suicidal Ideation |
6.1% |
| Urinary Tract Infection |
6.1% |
| Weight Increased |
6.1% |
| Bladder Disorder |
5.2% |
| Spinal Disorder |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Abdominal Hernia |
3.5% |
| Acth Stimulation Test |
3.5% |
| Acute Myeloid Leukaemia |
3.5% |
| Breast Cancer |
3.5% |
| Depression |
3.5% |
| Germ Cell Cancer |
3.5% |
| Maculopathy |
3.5% |
| Malaise |
3.5% |
| Progressive Multifocal Leukoencephalopathy |
3.5% |
| Rash |
3.5% |
| Rheumatoid Arthritis |
3.5% |
|
